摘要 |
<p>A physiologically active substance BE-16627 which is a novel inhibitor of stromelysin (human), represented by general formula (I), wherein R is a hydrogen atom or a methyl group, or a pharmaceutically acceptable salt thereof. Also disclosed are a process for preparing the same, a use of the same as a therapeutic agent for rheumatism and a cancer metastasis inhibitor, and a microorganism which produces BE-16627. <CHEM></p> |
申请人 |
BANYU PHARMACEUTICAL CO., LTD. |
发明人 |
KANBAYASHI, NOBUO BANYU PHARMACEUTICAL CO., LTD.;NAITO, KYOZO BANYU PHARMACEUTICAL CO., LTD.;OKUYAMA, AKIRA BANYU PHARMACEUTICAL CO., LTD.;SUZUKI, HAJIME BANYU PHARMACEUTICAL CO., LTD.;NAKAJIMA, SHIGERU BANYU PHARMACEUTICAL CO., LTD.;SUDA, HIROYUKI BANYU PHARMACEUTICAL CO., LTD.;OKANISHI, MASANORI BANYU PHARMACEUTICAL CO., LTD. |